290 related articles for article (PubMed ID: 19187271)
21. Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia.
Vrhovac R; Delmer A; Tang R; Marie JP; Zittoun R; Ajchenbaum-Cymbalista F
Blood; 1998 Jun; 91(12):4694-700. PubMed ID: 9616167
[TBL] [Abstract][Full Text] [Related]
22. Clinical tumor cell distribution pattern is a prognostically relevant parameter in patients with B-cell chronic lymphocytic leukemia.
Jaksic O; Vrhovac R; Kusec R; Kardum MM; Pandzic-Jaksic V; Kardum-Skelin I; Planinc-Peraica A; Morabito F; Brugiatelli M; Jaksic B
Haematologica; 2001 Aug; 86(8):827-36. PubMed ID: 11522539
[TBL] [Abstract][Full Text] [Related]
23. Comparative flow cytometric evaluation of bcl-2 oncoprotein in CD5+ and CD5- B-cell lymphoid chronic leukemias.
Molica S; Mannella A; Crispino G; Dattilo A; Levato D
Haematologica; 1997; 82(5):555-9. PubMed ID: 9407720
[TBL] [Abstract][Full Text] [Related]
24. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.
Büssing A; Stein GM; Stumpf C; Schietzel M
Anticancer Res; 1999; 19(5B):3953-9. PubMed ID: 10628337
[TBL] [Abstract][Full Text] [Related]
25. Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: case report.
Ahmad I; Al-Katib AM; Beck FW; Mohammad RM
Clin Cancer Res; 2000 Apr; 6(4):1328-32. PubMed ID: 10778958
[TBL] [Abstract][Full Text] [Related]
26. Phenomena of spontaneous proliferation, differentiation, and apoptosis in primary culture of leukemic lymphocytes.
Kalvelyté A; Pabrézaité L
Exp Cell Res; 1994 Apr; 211(2):344-52. PubMed ID: 8143782
[TBL] [Abstract][Full Text] [Related]
27. The relevance of multidrug resistance-associated P-glycoprotein expression in the treatment response of B-cell chronic lymphocytic leukemia.
Svoboda-Beusan I; Kusec R; Bendelja K; Tudoric-Ghemo I; Jaksic B; Pejsa V; Rabatic S; Vitale B
Haematologica; 2000 Dec; 85(12):1261-7. PubMed ID: 11114132
[TBL] [Abstract][Full Text] [Related]
28. [Ribosome content, spontaneous damage and repairing DNA synthesis in patients with chronic B-lymphocytic leukemia depending on stage and form of disease].
Morozova EO; Samuskevich IG; Blinov MN
Eksp Onkol; 1990; 12(3):28-31. PubMed ID: 2344820
[TBL] [Abstract][Full Text] [Related]
29. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
Dürig J; Naschar M; Schmücker U; Renzing-Köhler K; Hölter T; Hüttmann A; Dührsen U
Leukemia; 2002 Jan; 16(1):30-5. PubMed ID: 11840260
[TBL] [Abstract][Full Text] [Related]
30. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
[TBL] [Abstract][Full Text] [Related]
31. Cell cycle effects of IL-10 on malignant B-1 cells.
Yen Chong S; Lin YC; Czarneski J; Zhang M; Coffman F; Kashanchi F; Raveche E
Genes Immun; 2001 Aug; 2(5):239-47. PubMed ID: 11528515
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-2 prevents programmed cell death in chronic lymphocytic leukemia cells.
Huang RW; Tsuda H; Takatsuki K
Int J Hematol; 1993 Aug; 58(1-2):83-92. PubMed ID: 8219114
[TBL] [Abstract][Full Text] [Related]
33. B-chronic lymphocytic leukemia. Disease progression in 150 untreated stage A and B patients as predicted by bone marrow pattern.
Pangalis GA; Boussiotis VA; Kittas C
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):373-5. PubMed ID: 3222147
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in chronic lymphocytic leukaemia.
Binet JL
Haematologica; 1999 Jun; 84 Suppl EHA-4():96-7. PubMed ID: 10907482
[No Abstract] [Full Text] [Related]
35. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue.
Wołowiec D; Benchaib M; Pernas P; Deviller P; Souchier C; Rimokh R; Felman P; Bryon PA; Ffrench M
Leukemia; 1995 Aug; 9(8):1382-8. PubMed ID: 7643628
[TBL] [Abstract][Full Text] [Related]
36. Decreased immunoreactivity for cell-cycle regulator p27(Kip1) in Kaposi's sarcoma correlates with higher stage and extracutaneous involvement.
Fernández-Figueras MT; Puig L; Penín RM; Mate JL; Bigatà X; Ariza A
J Pathol; 2000 Aug; 191(4):387-93. PubMed ID: 10918213
[TBL] [Abstract][Full Text] [Related]
37. [Chronic lymphocytic leukemia in Japan].
Kobayashi T; Kita K; Ohno T; Shirakawa S
Rinsho Ketsueki; 1990 May; 31(5):554-63. PubMed ID: 2203917
[TBL] [Abstract][Full Text] [Related]
38. Clinico-prognostic implications of increased levels of soluble CD54 in the serum of B-cell chronic lymphocytic leukemia patients. Results of a multivariate survival analysis.
Molica S; Levato D; Dell' Olio M; Cascavilla N; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
Haematologica; 1997; 82(2):148-51. PubMed ID: 9175316
[TBL] [Abstract][Full Text] [Related]
39. [A benign form of chronic lympholeukemia].
Iakhnina EI; Nikitin EA; Astsaturov IA; Varlamova EIu; Kobzev IuN; Kovaleva LG; Kremenetskaia AM; Kulikov SM; Melikian AL; Pivnik AV; Samoĭlova RS; Vorob'ev AI
Ter Arkh; 1997; 69(7):11-7. PubMed ID: 9424751
[TBL] [Abstract][Full Text] [Related]
40. What is changing in the natural history of chronic lymphocytic leukemia?
Molica S; Levato D
Haematologica; 2001 Jan; 86(1):8-12. PubMed ID: 11146563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
